Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients

BACKGROUND: A validated prediction model estimates the absolute benefit of intensive versus standard lipid‐lowering therapy (LLT) with statins on next major cardiovascular events for individual patients with coronary artery disease. We aimed to assess whether targeting intensive LLT therapy to coron...

Descripción completa

Detalles Bibliográficos
Autores principales: Stam‐Slob, Manon C., van der Graaf, Yolanda, Greving, Jacoba P., Dorresteijn, Jannick A.N., Visseren, Frank L.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523762/
https://www.ncbi.nlm.nih.gov/pubmed/28214794
http://dx.doi.org/10.1161/JAHA.116.004648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523762/
https://www.ncbi.nlm.nih.gov/pubmed/28214794
http://dx.doi.org/10.1161/JAHA.116.004648

Ejemplares similares